These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3351005)

  • 1. Psychopharmacology of drugs effective in obsessive-compulsive disorder.
    Taniguchi G
    J Clin Psychopharmacol; 1988 Feb; 8(1):71. PubMed ID: 3351005
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential antidopaminergic effects of serotonin reuptake inhibitors.
    Kim SW; Dysken MW
    J Clin Psychiatry; 1991 Jan; 52(1):42. PubMed ID: 1988420
    [No Abstract]   [Full Text] [Related]  

  • 3. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ; Goodman WK; Leckman JF; Price LH
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers.
    de Montigny C; Blier P
    Arch Gen Psychiatry; 1991 May; 48(5):483-4. PubMed ID: 2021304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline therapy of obsessive-compulsive neurosis.
    Snyder S
    J Clin Psychiatry; 1980 Aug; 41(8):286-9. PubMed ID: 7400108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide response in obsessive-compulsive disorder.
    al Jeshi A
    Can J Psychiatry; 1999 Apr; 44(3):285. PubMed ID: 10225134
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test of dopamine-blocking potential of clomipramine.
    Kim SW; Dysken MW
    Am J Psychiatry; 1991 May; 148(5):690. PubMed ID: 2018183
    [No Abstract]   [Full Text] [Related]  

  • 14. Obsessive-compulsive disorder and its treatment with serotonin-selective agents.
    Murphy DL; Pigott TA
    Prog Clin Biol Res; 1990; 361():179-201. PubMed ID: 2290841
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of psychopharmacology in obsessive compulsive disorders.
    Sarwer-Foner GJ
    Psychiatr J Univ Ott; 1987 Nov; 12(4):197-202. PubMed ID: 3326003
    [No Abstract]   [Full Text] [Related]  

  • 17. Update of the serotonergic hypothesis of obsessive compulsive disorder.
    Zohar J; Kindler S
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():257A-258A. PubMed ID: 1386779
    [No Abstract]   [Full Text] [Related]  

  • 18. Animal models in obsessive compulsive disorder.
    Olivier B
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract]   [Full Text] [Related]  

  • 19. MAOI for obsessive compulsive disorder.
    Jenike MA
    Br J Psychiatry; 1982 May; 140():549. PubMed ID: 7104541
    [No Abstract]   [Full Text] [Related]  

  • 20. EDITORIAL: Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
    Del Casale A; Kotzalidis GD; Rapinesi C; Girardi P
    Curr Neuropharmacol; 2019 Aug; 17(8):668-671. PubMed ID: 32194358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.